omar-sharif03/PHEE-processed · Datasets at Hugging Face

serial-number stringlengths 7 11	id stringlengths 7 11	event stringclasses 2 values	trigger listlengths 1 1	is-multi-event bool 2 classes	context stringlengths 24 527	argument-type stringclasses 3 values	role stringclasses 15 values	raw-initial-ground-truth listlengths 1 6
train-101	8586895_3	adverse_event	[ "following" ]	false	Prolongation of the QT interval observed in a Japanese patient with vivax malaria following treatment with halofantrine.	treatment	treatment-route	[ "null" ]
train-102	8586895_3	adverse_event	[ "following" ]	false	Prolongation of the QT interval observed in a Japanese patient with vivax malaria following treatment with halofantrine.	treatment	treatment-dosage	[ "null" ]
train-103	8586895_3	adverse_event	[ "following" ]	false	Prolongation of the QT interval observed in a Japanese patient with vivax malaria following treatment with halofantrine.	treatment	treatment-time_elasped	[ "null" ]
train-104	8586895_3	adverse_event	[ "following" ]	false	Prolongation of the QT interval observed in a Japanese patient with vivax malaria following treatment with halofantrine.	treatment	treatment-duration	[ "null" ]
train-105	8586895_3	adverse_event	[ "following" ]	false	Prolongation of the QT interval observed in a Japanese patient with vivax malaria following treatment with halofantrine.	treatment	treatment-freq	[ "null" ]
train-106	7776854_3	adverse_event	[ "related" ]	false	We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.	main-arguments	subject	[ "three cases" ]
train-107	7776854_3	adverse_event	[ "related" ]	false	We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.	main-arguments	treatment	[ "benzarone" ]
train-108	7776854_3	adverse_event	[ "related" ]	false	We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.	main-arguments	effect	[ "severe hepatotoxicity" ]
train-109	7776854_3	adverse_event	[ "related" ]	false	We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.	subject	subject-age	[ "null" ]
train-110	7776854_3	adverse_event	[ "related" ]	false	We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.	subject	subject-disorder	[ "null" ]
train-111	7776854_3	adverse_event	[ "related" ]	false	We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.	subject	subject-gender	[ "null" ]
train-112	7776854_3	adverse_event	[ "related" ]	false	We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.	subject	subject-population	[ "three" ]
train-113	7776854_3	adverse_event	[ "related" ]	false	We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.	subject	subject-race	[ "null" ]
train-114	7776854_3	adverse_event	[ "related" ]	false	We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.	treatment	treatment-drug	[ "benzarone" ]
train-115	7776854_3	adverse_event	[ "related" ]	false	We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.	treatment	treatment-disorder	[ "null" ]
train-116	7776854_3	adverse_event	[ "related" ]	false	We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.	treatment	treatment-route	[ "null" ]
train-117	7776854_3	adverse_event	[ "related" ]	false	We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.	treatment	treatment-dosage	[ "null" ]
train-118	7776854_3	adverse_event	[ "related" ]	false	We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.	treatment	treatment-time_elasped	[ "null" ]
train-119	7776854_3	adverse_event	[ "related" ]	false	We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.	treatment	treatment-duration	[ "null" ]
train-120	7776854_3	adverse_event	[ "related" ]	false	We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.	treatment	treatment-freq	[ "null" ]
train-121	8024670_1	adverse_event	[ "symptoms of" ]	false	Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.	main-arguments	subject	[ "Four patients" ]
train-122	8024670_1	adverse_event	[ "symptoms of" ]	false	Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.	main-arguments	treatment	[ "antiepileptic drug (AED)", "during therapy with carbamazepine" ]
train-123	8024670_1	adverse_event	[ "symptoms of" ]	false	Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.	main-arguments	effect	[ "hypersensitivity syndrome" ]
train-124	8024670_1	adverse_event	[ "symptoms of" ]	false	Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.	subject	subject-age	[ "null" ]
train-125	8024670_1	adverse_event	[ "symptoms of" ]	false	Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.	subject	subject-disorder	[ "null" ]
train-126	8024670_1	adverse_event	[ "symptoms of" ]	false	Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.	subject	subject-gender	[ "null" ]
train-127	8024670_1	adverse_event	[ "symptoms of" ]	false	Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.	subject	subject-population	[ "Four" ]
train-128	8024670_1	adverse_event	[ "symptoms of" ]	false	Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.	subject	subject-race	[ "null" ]
train-129	8024670_1	adverse_event	[ "symptoms of" ]	false	Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.	treatment	treatment-drug	[ "antiepileptic drug (AED)", "carbamazepine" ]
train-130	8024670_1	adverse_event	[ "symptoms of" ]	false	Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.	treatment	treatment-disorder	[ "null" ]
train-131	8024670_1	adverse_event	[ "symptoms of" ]	false	Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.	treatment	treatment-route	[ "null" ]
train-132	8024670_1	adverse_event	[ "symptoms of" ]	false	Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.	treatment	treatment-dosage	[ "null" ]
train-133	8024670_1	adverse_event	[ "symptoms of" ]	false	Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.	treatment	treatment-time_elasped	[ "null" ]
train-134	8024670_1	adverse_event	[ "symptoms of" ]	false	Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.	treatment	treatment-duration	[ "null" ]
train-135	8024670_1	adverse_event	[ "symptoms of" ]	false	Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.	treatment	treatment-freq	[ "null" ]
train-136	11026106_1	adverse_event	[ "induced" ]	false	Minocycline as a cause of drug-induced autoimmune hepatitis.	main-arguments	subject	[ "null" ]
train-137	11026106_1	adverse_event	[ "induced" ]	false	Minocycline as a cause of drug-induced autoimmune hepatitis.	main-arguments	treatment	[ "Minocycline" ]
train-138	11026106_1	adverse_event	[ "induced" ]	false	Minocycline as a cause of drug-induced autoimmune hepatitis.	main-arguments	effect	[ "autoimmune hepatitis" ]
train-139	11026106_1	adverse_event	[ "induced" ]	false	Minocycline as a cause of drug-induced autoimmune hepatitis.	subject	subject-age	[ "null" ]
train-140	11026106_1	adverse_event	[ "induced" ]	false	Minocycline as a cause of drug-induced autoimmune hepatitis.	subject	subject-disorder	[ "null" ]
train-141	11026106_1	adverse_event	[ "induced" ]	false	Minocycline as a cause of drug-induced autoimmune hepatitis.	subject	subject-gender	[ "null" ]
train-142	11026106_1	adverse_event	[ "induced" ]	false	Minocycline as a cause of drug-induced autoimmune hepatitis.	subject	subject-population	[ "null" ]
train-143	11026106_1	adverse_event	[ "induced" ]	false	Minocycline as a cause of drug-induced autoimmune hepatitis.	subject	subject-race	[ "null" ]
train-144	11026106_1	adverse_event	[ "induced" ]	false	Minocycline as a cause of drug-induced autoimmune hepatitis.	treatment	treatment-drug	[ "Minocycline" ]
train-145	11026106_1	adverse_event	[ "induced" ]	false	Minocycline as a cause of drug-induced autoimmune hepatitis.	treatment	treatment-disorder	[ "null" ]
train-146	11026106_1	adverse_event	[ "induced" ]	false	Minocycline as a cause of drug-induced autoimmune hepatitis.	treatment	treatment-route	[ "null" ]
train-147	11026106_1	adverse_event	[ "induced" ]	false	Minocycline as a cause of drug-induced autoimmune hepatitis.	treatment	treatment-dosage	[ "null" ]
train-148	11026106_1	adverse_event	[ "induced" ]	false	Minocycline as a cause of drug-induced autoimmune hepatitis.	treatment	treatment-time_elasped	[ "null" ]
train-149	11026106_1	adverse_event	[ "induced" ]	false	Minocycline as a cause of drug-induced autoimmune hepatitis.	treatment	treatment-duration	[ "null" ]
train-150	11026106_1	adverse_event	[ "induced" ]	false	Minocycline as a cause of drug-induced autoimmune hepatitis.	treatment	treatment-freq	[ "null" ]
train-151	19434733_1	adverse_event	[ "after" ]	false	Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.	main-arguments	subject	[ "null" ]
train-152	19434733_1	adverse_event	[ "after" ]	false	Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.	main-arguments	treatment	[ "etoposide therapy" ]
train-153	19434733_1	adverse_event	[ "after" ]	false	Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.	main-arguments	effect	[ "Secondary acute myeloid leukemia" ]
train-154	19434733_1	adverse_event	[ "after" ]	false	Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.	subject	subject-age	[ "null" ]
train-155	19434733_1	adverse_event	[ "after" ]	false	Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.	subject	subject-disorder	[ "null" ]
train-156	19434733_1	adverse_event	[ "after" ]	false	Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.	subject	subject-gender	[ "null" ]
train-157	19434733_1	adverse_event	[ "after" ]	false	Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.	subject	subject-population	[ "null" ]
train-158	19434733_1	adverse_event	[ "after" ]	false	Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.	subject	subject-race	[ "null" ]
train-159	19434733_1	adverse_event	[ "after" ]	false	Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.	treatment	treatment-drug	[ "etoposide" ]
train-160	19434733_1	adverse_event	[ "after" ]	false	Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.	treatment	treatment-disorder	[ "haemophagocytic lymphohistiocytosis" ]
train-161	19434733_1	adverse_event	[ "after" ]	false	Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.	treatment	treatment-route	[ "null" ]
train-162	19434733_1	adverse_event	[ "after" ]	false	Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.	treatment	treatment-dosage	[ "null" ]
train-163	19434733_1	adverse_event	[ "after" ]	false	Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.	treatment	treatment-time_elasped	[ "null" ]
train-164	19434733_1	adverse_event	[ "after" ]	false	Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.	treatment	treatment-duration	[ "null" ]
train-165	19434733_1	adverse_event	[ "after" ]	false	Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.	treatment	treatment-freq	[ "null" ]
train-166	16882109_1	adverse_event	[ "to" ]	false	Allergic contact angioedema to benzoyl peroxide.	main-arguments	subject	[ "null" ]
train-167	16882109_1	adverse_event	[ "to" ]	false	Allergic contact angioedema to benzoyl peroxide.	main-arguments	treatment	[ "benzoyl peroxide" ]
train-168	16882109_1	adverse_event	[ "to" ]	false	Allergic contact angioedema to benzoyl peroxide.	main-arguments	effect	[ "Allergic contact angioedema" ]
train-169	16882109_1	adverse_event	[ "to" ]	false	Allergic contact angioedema to benzoyl peroxide.	subject	subject-age	[ "null" ]
train-170	16882109_1	adverse_event	[ "to" ]	false	Allergic contact angioedema to benzoyl peroxide.	subject	subject-disorder	[ "null" ]
train-171	16882109_1	adverse_event	[ "to" ]	false	Allergic contact angioedema to benzoyl peroxide.	subject	subject-gender	[ "null" ]
train-172	16882109_1	adverse_event	[ "to" ]	false	Allergic contact angioedema to benzoyl peroxide.	subject	subject-population	[ "null" ]
train-173	16882109_1	adverse_event	[ "to" ]	false	Allergic contact angioedema to benzoyl peroxide.	subject	subject-race	[ "null" ]
train-174	16882109_1	adverse_event	[ "to" ]	false	Allergic contact angioedema to benzoyl peroxide.	treatment	treatment-drug	[ "benzoyl peroxide" ]
train-175	16882109_1	adverse_event	[ "to" ]	false	Allergic contact angioedema to benzoyl peroxide.	treatment	treatment-disorder	[ "null" ]
train-176	16882109_1	adverse_event	[ "to" ]	false	Allergic contact angioedema to benzoyl peroxide.	treatment	treatment-route	[ "null" ]
train-177	16882109_1	adverse_event	[ "to" ]	false	Allergic contact angioedema to benzoyl peroxide.	treatment	treatment-dosage	[ "null" ]
train-178	16882109_1	adverse_event	[ "to" ]	false	Allergic contact angioedema to benzoyl peroxide.	treatment	treatment-time_elasped	[ "null" ]
train-179	16882109_1	adverse_event	[ "to" ]	false	Allergic contact angioedema to benzoyl peroxide.	treatment	treatment-duration	[ "null" ]
train-180	16882109_1	adverse_event	[ "to" ]	false	Allergic contact angioedema to benzoyl peroxide.	treatment	treatment-freq	[ "null" ]
train-181	1244265_1	adverse_event	[ "develop" ]	false	A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.	main-arguments	subject	[ "A 60-year-old white man with chronic bronchitis" ]
train-182	1244265_1	adverse_event	[ "develop" ]	false	A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.	main-arguments	treatment	[ "methazolamide (Neptazane)" ]
train-183	1244265_1	adverse_event	[ "develop" ]	false	A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.	main-arguments	effect	[ "acute respiratory failure and metabolic acidosis" ]
train-184	1244265_1	adverse_event	[ "develop" ]	false	A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.	subject	subject-age	[ "60-year-old" ]
train-185	1244265_1	adverse_event	[ "develop" ]	false	A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.	subject	subject-disorder	[ "chronic bronchitis", "ophthalmologic problem" ]
train-186	1244265_1	adverse_event	[ "develop" ]	false	A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.	subject	subject-gender	[ "man" ]
train-187	1244265_1	adverse_event	[ "develop" ]	false	A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.	subject	subject-population	[ "null" ]
train-188	1244265_1	adverse_event	[ "develop" ]	false	A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.	subject	subject-race	[ "white" ]
train-189	1244265_1	adverse_event	[ "develop" ]	false	A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.	treatment	treatment-drug	[ "methazolamide" ]
train-190	1244265_1	adverse_event	[ "develop" ]	false	A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.	treatment	treatment-disorder	[ "ophthalmologic problem" ]
train-191	1244265_1	adverse_event	[ "develop" ]	false	A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.	treatment	treatment-route	[ "null" ]
train-192	1244265_1	adverse_event	[ "develop" ]	false	A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.	treatment	treatment-dosage	[ "null" ]
train-193	1244265_1	adverse_event	[ "develop" ]	false	A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.	treatment	treatment-time_elasped	[ "null" ]
train-194	1244265_1	adverse_event	[ "develop" ]	false	A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.	treatment	treatment-duration	[ "four days" ]
train-195	1244265_1	adverse_event	[ "develop" ]	false	A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.	treatment	treatment-freq	[ "null" ]
train-196	14557583_2	adverse_event	[ "induced" ]	false	L-DOPA-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment.	main-arguments	subject	[ "null" ]
train-197	14557583_2	adverse_event	[ "induced" ]	false	L-DOPA-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment.	main-arguments	treatment	[ "L-DOPA" ]
train-198	14557583_2	adverse_event	[ "induced" ]	false	L-DOPA-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment.	main-arguments	effect	[ "daytime sleepiness" ]
train-199	14557583_2	adverse_event	[ "induced" ]	false	L-DOPA-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment.	subject	subject-age	[ "null" ]
train-200	14557583_2	adverse_event	[ "induced" ]	false	L-DOPA-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment.	subject	subject-disorder	[ "null" ]

train-101

8586895_3

adverse_event

[ "following" ]

false

Prolongation of the QT interval observed in a Japanese patient with vivax malaria following treatment with halofantrine.

treatment

treatment-route

[ "null" ]

train-102

8586895_3

adverse_event

[ "following" ]

false

Prolongation of the QT interval observed in a Japanese patient with vivax malaria following treatment with halofantrine.

treatment

treatment-dosage

[ "null" ]

train-103

8586895_3

adverse_event

[ "following" ]

false

Prolongation of the QT interval observed in a Japanese patient with vivax malaria following treatment with halofantrine.

treatment

treatment-time_elasped

[ "null" ]

train-104

8586895_3

adverse_event

[ "following" ]

false

Prolongation of the QT interval observed in a Japanese patient with vivax malaria following treatment with halofantrine.

treatment

treatment-duration

[ "null" ]

train-105

8586895_3

adverse_event

[ "following" ]

false

Prolongation of the QT interval observed in a Japanese patient with vivax malaria following treatment with halofantrine.

treatment

treatment-freq

[ "null" ]

train-106

7776854_3

adverse_event

[ "related" ]

false

We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.

main-arguments

subject

[ "three cases" ]

train-107

7776854_3

adverse_event

[ "related" ]

false

We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.

main-arguments

treatment

[ "benzarone" ]

train-108

7776854_3

adverse_event

[ "related" ]

false

We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.

main-arguments

effect

[ "severe hepatotoxicity" ]

train-109

7776854_3

adverse_event

[ "related" ]

false

We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.

subject

subject-age

[ "null" ]

train-110

7776854_3

adverse_event

[ "related" ]

false

We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.

subject

subject-disorder

[ "null" ]

train-111

7776854_3

adverse_event

[ "related" ]

false

We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.

subject

subject-gender

[ "null" ]

train-112

7776854_3

adverse_event

[ "related" ]

false

We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.

subject

subject-population

[ "three" ]

train-113

7776854_3

adverse_event

[ "related" ]

false

We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.

subject

subject-race

[ "null" ]

train-114

7776854_3

adverse_event

[ "related" ]

false

We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.

treatment

treatment-drug

[ "benzarone" ]

train-115

7776854_3

adverse_event

[ "related" ]

false

We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.

treatment

treatment-disorder

[ "null" ]

train-116

7776854_3

adverse_event

[ "related" ]

false

We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.

treatment

treatment-route

[ "null" ]

train-117

7776854_3

adverse_event

[ "related" ]

false

We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.

treatment

treatment-dosage

[ "null" ]

train-118

7776854_3

adverse_event

[ "related" ]

false

We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.

treatment

treatment-time_elasped

[ "null" ]

train-119

7776854_3

adverse_event

[ "related" ]

false

We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.

treatment

treatment-duration

[ "null" ]

train-120

7776854_3

adverse_event

[ "related" ]

false

We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.

treatment

treatment-freq

[ "null" ]

train-121

8024670_1

adverse_event

[ "symptoms of" ]

false

Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.

main-arguments

subject

[ "Four patients" ]

train-122

8024670_1

adverse_event

[ "symptoms of" ]

false

Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.

main-arguments

treatment

[ "antiepileptic drug (AED)", "during therapy with carbamazepine" ]

train-123

8024670_1

adverse_event

[ "symptoms of" ]

false

Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.

main-arguments

effect

[ "hypersensitivity syndrome" ]

train-124

8024670_1

adverse_event

[ "symptoms of" ]

false

Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.

subject

subject-age

[ "null" ]

train-125

8024670_1

adverse_event

[ "symptoms of" ]

false

Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.

subject

subject-disorder

[ "null" ]

train-126

8024670_1

adverse_event

[ "symptoms of" ]

false

Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.

subject

subject-gender

[ "null" ]

train-127

8024670_1

adverse_event

[ "symptoms of" ]

false

Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.

subject

subject-population

[ "Four" ]

train-128

8024670_1

adverse_event

[ "symptoms of" ]

false

Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.

subject

subject-race

[ "null" ]

train-129

8024670_1

adverse_event

[ "symptoms of" ]

false

Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.

treatment

treatment-drug

[ "antiepileptic drug (AED)", "carbamazepine" ]

train-130

8024670_1

adverse_event

[ "symptoms of" ]

false

Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.

treatment

treatment-disorder

[ "null" ]

train-131

8024670_1

adverse_event

[ "symptoms of" ]

false

Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.

treatment

treatment-route

[ "null" ]

train-132

8024670_1

adverse_event

[ "symptoms of" ]

false

Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.

treatment

treatment-dosage

[ "null" ]

train-133

8024670_1

adverse_event

[ "symptoms of" ]

false

Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.

treatment

treatment-time_elasped

[ "null" ]

train-134

8024670_1

adverse_event

[ "symptoms of" ]

false

Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.

treatment

treatment-duration

[ "null" ]

train-135

8024670_1

adverse_event

[ "symptoms of" ]

false

Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.

treatment

treatment-freq

[ "null" ]

train-136

11026106_1

adverse_event

[ "induced" ]

false

Minocycline as a cause of drug-induced autoimmune hepatitis.

main-arguments

subject

[ "null" ]

train-137

11026106_1

adverse_event

[ "induced" ]

false

Minocycline as a cause of drug-induced autoimmune hepatitis.

main-arguments

treatment

[ "Minocycline" ]

train-138

11026106_1

adverse_event

[ "induced" ]

false

Minocycline as a cause of drug-induced autoimmune hepatitis.

main-arguments

effect

[ "autoimmune hepatitis" ]

train-139

11026106_1

adverse_event

[ "induced" ]

false

Minocycline as a cause of drug-induced autoimmune hepatitis.

subject

subject-age

[ "null" ]

train-140

11026106_1

adverse_event

[ "induced" ]

false

Minocycline as a cause of drug-induced autoimmune hepatitis.

subject

subject-disorder

[ "null" ]

train-141

11026106_1

adverse_event

[ "induced" ]

false

Minocycline as a cause of drug-induced autoimmune hepatitis.

subject

subject-gender

[ "null" ]

train-142

11026106_1

adverse_event

[ "induced" ]

false

Minocycline as a cause of drug-induced autoimmune hepatitis.

subject

subject-population

[ "null" ]

train-143

11026106_1

adverse_event

[ "induced" ]

false

Minocycline as a cause of drug-induced autoimmune hepatitis.

subject

subject-race

[ "null" ]

train-144

11026106_1

adverse_event

[ "induced" ]

false

Minocycline as a cause of drug-induced autoimmune hepatitis.

treatment

treatment-drug

[ "Minocycline" ]

train-145

11026106_1

adverse_event

[ "induced" ]

false

Minocycline as a cause of drug-induced autoimmune hepatitis.

treatment

treatment-disorder

[ "null" ]

train-146

11026106_1

adverse_event

[ "induced" ]

false

Minocycline as a cause of drug-induced autoimmune hepatitis.

treatment

treatment-route

[ "null" ]

train-147

11026106_1

adverse_event

[ "induced" ]

false

Minocycline as a cause of drug-induced autoimmune hepatitis.

treatment

treatment-dosage

[ "null" ]

train-148

11026106_1

adverse_event

[ "induced" ]

false

Minocycline as a cause of drug-induced autoimmune hepatitis.

treatment

treatment-time_elasped

[ "null" ]

train-149

11026106_1

adverse_event

[ "induced" ]

false

Minocycline as a cause of drug-induced autoimmune hepatitis.

treatment

treatment-duration

[ "null" ]

train-150

11026106_1

adverse_event

[ "induced" ]

false

Minocycline as a cause of drug-induced autoimmune hepatitis.

treatment

treatment-freq

[ "null" ]

train-151

19434733_1

adverse_event

[ "after" ]

false

Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.

main-arguments

subject

[ "null" ]

train-152

19434733_1

adverse_event

[ "after" ]

false

Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.

main-arguments

treatment

[ "etoposide therapy" ]

train-153

19434733_1

adverse_event

[ "after" ]

false

Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.

main-arguments

effect

[ "Secondary acute myeloid leukemia" ]

train-154

19434733_1

adverse_event

[ "after" ]

false

Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.

subject

subject-age

[ "null" ]

train-155

19434733_1

adverse_event

[ "after" ]

false

Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.

subject

subject-disorder

[ "null" ]

train-156

19434733_1

adverse_event

[ "after" ]

false

Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.

subject

subject-gender

[ "null" ]

train-157

19434733_1

adverse_event

[ "after" ]

false

Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.

subject

subject-population

[ "null" ]

train-158

19434733_1

adverse_event

[ "after" ]

false

Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.

subject

subject-race

[ "null" ]

train-159

19434733_1

adverse_event

[ "after" ]

false

Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.

treatment

treatment-drug

[ "etoposide" ]

train-160

19434733_1

adverse_event

[ "after" ]

false

Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.

treatment

treatment-disorder

[ "haemophagocytic lymphohistiocytosis" ]

train-161

19434733_1

adverse_event

[ "after" ]

false

Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.

treatment

treatment-route

[ "null" ]

train-162

19434733_1

adverse_event

[ "after" ]

false

Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.

treatment

treatment-dosage

[ "null" ]

train-163

19434733_1

adverse_event

[ "after" ]

false

Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.

treatment

treatment-time_elasped

[ "null" ]

train-164

19434733_1

adverse_event

[ "after" ]

false

Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.

treatment

treatment-duration

[ "null" ]

train-165

19434733_1

adverse_event

[ "after" ]

false

Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.

treatment

treatment-freq

[ "null" ]

train-166

16882109_1

adverse_event

[ "to" ]

false

Allergic contact angioedema to benzoyl peroxide.

main-arguments

subject

[ "null" ]

train-167

16882109_1

adverse_event

[ "to" ]

false

Allergic contact angioedema to benzoyl peroxide.

main-arguments

treatment

[ "benzoyl peroxide" ]

train-168

16882109_1

adverse_event

[ "to" ]

false

Allergic contact angioedema to benzoyl peroxide.

main-arguments

effect

[ "Allergic contact angioedema" ]

train-169

16882109_1

adverse_event

[ "to" ]

false

Allergic contact angioedema to benzoyl peroxide.

subject

subject-age

[ "null" ]

train-170

16882109_1

adverse_event

[ "to" ]

false

Allergic contact angioedema to benzoyl peroxide.

subject

subject-disorder

[ "null" ]

train-171

16882109_1

adverse_event

[ "to" ]

false

Allergic contact angioedema to benzoyl peroxide.

subject

subject-gender

[ "null" ]

train-172

16882109_1

adverse_event

[ "to" ]

false

Allergic contact angioedema to benzoyl peroxide.

subject

subject-population

[ "null" ]

train-173

16882109_1

adverse_event

[ "to" ]

false

Allergic contact angioedema to benzoyl peroxide.

subject

subject-race

[ "null" ]

train-174

16882109_1

adverse_event

[ "to" ]

false

Allergic contact angioedema to benzoyl peroxide.

treatment

treatment-drug

[ "benzoyl peroxide" ]

train-175

16882109_1

adverse_event

[ "to" ]

false

Allergic contact angioedema to benzoyl peroxide.

treatment

treatment-disorder

[ "null" ]

train-176

16882109_1

adverse_event

[ "to" ]

false

Allergic contact angioedema to benzoyl peroxide.

treatment

treatment-route

[ "null" ]

train-177

16882109_1

adverse_event

[ "to" ]

false

Allergic contact angioedema to benzoyl peroxide.

treatment

treatment-dosage

[ "null" ]

train-178

16882109_1

adverse_event

[ "to" ]

false

Allergic contact angioedema to benzoyl peroxide.

treatment

treatment-time_elasped

[ "null" ]

train-179

16882109_1

adverse_event

[ "to" ]

false

Allergic contact angioedema to benzoyl peroxide.

treatment

treatment-duration

[ "null" ]

train-180

16882109_1

adverse_event

[ "to" ]

false

Allergic contact angioedema to benzoyl peroxide.

treatment

treatment-freq

[ "null" ]

train-181

1244265_1

adverse_event

[ "develop" ]

false

A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.

main-arguments

subject

[ "A 60-year-old white man with chronic bronchitis" ]

train-182

1244265_1

adverse_event

[ "develop" ]

false

A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.

main-arguments

treatment

[ "methazolamide (Neptazane)" ]

train-183

1244265_1

adverse_event

[ "develop" ]

false

A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.

main-arguments

effect

[ "acute respiratory failure and metabolic acidosis" ]

train-184

1244265_1

adverse_event

[ "develop" ]

false

A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.

subject

subject-age

[ "60-year-old" ]

train-185

1244265_1

adverse_event

[ "develop" ]

false

A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.

subject

subject-disorder

[ "chronic bronchitis", "ophthalmologic problem" ]

train-186

1244265_1

adverse_event

[ "develop" ]

false

A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.

subject

subject-gender

[ "man" ]

train-187

1244265_1

adverse_event

[ "develop" ]

false

A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.

subject

subject-population

[ "null" ]

train-188

1244265_1

adverse_event

[ "develop" ]

false

A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.

subject

subject-race

[ "white" ]

train-189

1244265_1

adverse_event

[ "develop" ]

false

A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.

treatment

treatment-drug

[ "methazolamide" ]

train-190

1244265_1

adverse_event

[ "develop" ]

false

A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.

treatment

treatment-disorder

[ "ophthalmologic problem" ]

train-191

1244265_1

adverse_event

[ "develop" ]

false

A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.

treatment

treatment-route

[ "null" ]

train-192

1244265_1

adverse_event

[ "develop" ]

false

A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.

treatment

treatment-dosage

[ "null" ]

train-193

1244265_1

adverse_event

[ "develop" ]

false

A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.

treatment

treatment-time_elasped

[ "null" ]

train-194

1244265_1

adverse_event

[ "develop" ]

false

A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.

treatment

treatment-duration

[ "four days" ]

train-195

1244265_1

adverse_event

[ "develop" ]

false

A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.

treatment

treatment-freq

[ "null" ]

train-196

14557583_2

adverse_event

[ "induced" ]

false

L-DOPA-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment.

main-arguments

subject

[ "null" ]

train-197

14557583_2

adverse_event

[ "induced" ]

false

L-DOPA-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment.

main-arguments

treatment

[ "L-DOPA" ]

train-198

14557583_2

adverse_event

[ "induced" ]

false

L-DOPA-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment.

main-arguments

effect

[ "daytime sleepiness" ]

train-199

14557583_2

adverse_event

[ "induced" ]

false

L-DOPA-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment.

subject

subject-age

[ "null" ]

train-200

14557583_2

adverse_event

[ "induced" ]

false

L-DOPA-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment.

subject

subject-disorder

[ "null" ]